None listed
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
dr Sampreeta Lakshmi P
Eligibility
Inclusion criteria
Inclusion criteria: ASA 1 and 2 patients undergoing surgeries under spinal anaesthesia
Exclusion criteria
Exclusion criteria: Patient with allergy to opioids preexisting pruritis; preeclampsia; diabetes mellitus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) To estimate the incidence of pruritic with intrathecal fentanyl and buprenorphine 2) To see the pattern of pruritis following intrathecal fentanyl and buprenorphine administration 3) To compare the incidence and pattern of pruitis between fentanyl and buprenorphine. Timepoint: During operative and 1 hour post operative duration | — |
Secondary
| Measure | Time frame |
|---|---|
| to look for risk factors, association and pattern of distribution of pruritus with intrathecal fentanyl and intrathecal buprenorphineTimepoint: during operative and one hour post operative duration | — |
Countries
India
Contacts
Public ContactSampreeta Lakshmi Pradeep
Outcome results
None listed